A nurse is caring for a client receiving an intermittent IV bolus of gentamicin twice daily. Which of the following laboratory values should the nurse monitor while the client is receiving this medication? (Select all that apply.)
Glucose.
Prothrombin time.
Serum creatinine.
Cardiac enzymes.
WBC count.
Correct Answer : C,E
Choice A rationale
Monitoring glucose levels is not typically necessary for patients receiving gentamicin, as it does not significantly affect glucose metabolism.
Choice B rationale
Prothrombin time is not commonly affected by gentamicin, so routine monitoring is not required.
Choice C rationale
Serum creatinine levels should be monitored to assess kidney function, as gentamicin can cause nephrotoxicity.
Choice D rationale
Cardiac enzymes are not typically affected by gentamicin, so routine monitoring is not necessary.
Choice E rationale
Monitoring WBC count is important to detect any signs of infection or bone marrow suppression, which can occur with gentamicin use.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is D
Explanation
Choice A rationale
Sitagliptin is a DPP-4 inhibitor used to manage blood sugar levels in type 2 diabetes but does not specifically slow the progression of nephropathy.
Choice B rationale
Glipizide is a sulfonylurea that helps control blood sugar levels but does not have a direct effect on slowing nephropathy progression.
Choice C rationale
Metoprolol is a beta-blocker used to manage hypertension but does not specifically target nephropathy progression.
Choice D rationale
Losartan is an angiotensin II receptor blocker (ARB) that helps manage hypertension and has been shown to slow the progression of nephropathy in patients with type 2 diabetes.
Correct Answer is C
Explanation
Choice A rationale
Incorrect packaging, such as a topical medication packaged as an oral medication, can lead to medication errors. However, it is not the most frequent cause of fatal medication errors. Packaging errors are relatively rare and usually caught before administration.
Choice B rationale
Delivery device problems, such as an infusion pump malfunction, can cause medication errors. These errors can be serious but are not the most frequent cause of fatal medication errors. Device malfunctions are often detected and corrected by healthcare professionals.
Choice C rationale
Name confusion between two medications with similar sounding names is the most frequent cause of fatal medication errors. This type of error occurs when medications with similar names are confused, leading to the administration of the wrong drug. This can have serious and sometimes fatal consequences.
Choice D rationale
Incorrect labeling of a medication dispensed by the pharmacy can lead to medication errors. While labeling errors are a significant concern, they are not the most frequent cause of fatal medication errors. These errors are often identified and corrected before administration.